Form 4: Orchestra BioMed Executive Yuval Mika Reports Stock Award and Disposal

Sentiment:

SEC Form 4


Yuval Mika, General Manager and Chief Technology Officer at Orchestra BioMed, reports the acquisition of restricted stock units and disposal of common stock.

Summary

  • On May 8, 2024, Yuval Mika, General Manager and Chief Technology Officer at Orchestra BioMed Holdings, Inc., reported transactions involving the company's stock.
  • Mika acquired 69,333 shares of common stock through an award of restricted stock units (RSUs) at a price of $0.
  • These RSUs vest in installments between May 18, 2025, and May 18, 2028, contingent upon continuous service.
  • Mika also disposed of 69,333 shares of common stock.
  • Following these transactions, Mika beneficially owns 158,905 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The RSU award could be seen as a positive, but it's a routine part of executive compensation.

Positives

  • The award of RSUs to a key executive like Yuval Mika can be seen as a positive sign, aligning their interests with the long-term success of Orchestra BioMed.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates changes in the holdings of a key executive at Orchestra BioMed.

Stakeholder Impact

  • Shareholders may view the RSU award as an incentive for the executive to perform well, potentially increasing shareholder value.

Key Dates

DateDescription
05/08/2024Date of the reported transactions (acquisition and disposal of shares).
05/18/2025First vesting date for 10,400 of the awarded RSUs.
08/18/2025Next vesting date for the remaining 58,933 RSUs in equal installments.
11/18/2025Next vesting date for the remaining 58,933 RSUs in equal installments.
12/18/2025Next vesting date for the remaining 58,933 RSUs in equal installments.
05/18/2026Next vesting date for the remaining 58,933 RSUs in equal installments.
08/18/2026Next vesting date for the remaining 58,933 RSUs in equal installments.
11/18/2026Next vesting date for the remaining 58,933 RSUs in equal installments.
03/25/2027Next vesting date for the remaining 58,933 RSUs in equal installments.
05/18/2027Next vesting date for the remaining 58,933 RSUs in equal installments.
08/18/2027Next vesting date for the remaining 58,933 RSUs in equal installments.
11/18/2027Next vesting date for the remaining 58,933 RSUs in equal installments.
03/25/2028Next vesting date for the remaining 58,933 RSUs in equal installments.
05/18/2028Final vesting date for the remaining 58,933 RSUs.
05/10/2024Date of the report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.